In Vivo Therapy of Neoplastic Meningitis with Methotrexate and 5-[¹²⁵I]iodo-2'-deoxyuridine

References

• Grossman SA, Moynihan TJ. Neoplastic meningitis. Neurol Clin 1991; 9: 843–56.
   PubMed Web of Science ®Google Scholar
• Patchell RA, Posner JB. Neurologic complications of systemic cancer. Neurol Clin 1985; 3: 729–50.
   PubMed Web of Science ®Google Scholar
• MacKintosh FR, Colby TV, Podolsky WJ, et al. Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer 1982; 49: 586–95.
   PubMed Web of Science ®Google Scholar
• Stewart DJ, Keating MJ, McCredie KB, et al. Natural history of central nervous system acute leukemia in adults. Cancer 1981; 47: 184–96.
   PubMed Web of Science ®Google Scholar
• Berry MP, Jenkin RDT, Keen CW, Nair BD, Simpson WJ. Radiation treatment for medulloblastoma: a 21-year review. J Neurosurg 1981; 55: 43–51.
   Google Scholar
• Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS, for the Eastern Cooperative On-cology Group. Randomized prospective comparison of intra-ventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 1993; 11: 561–9.
   Google Scholar
• Shapiro WR, Posner JB, Ushio Y, Chemik NL, Young DF. Treatment of meningeal neoplasms. Cancer Treat Rep 1977; 61: 733–43.
   PubMedGoogle Scholar
• Trump DL, Grossman SA, Thompson G, Murray K, Wharam M. Treatment of neoplastic meningitis with intra-ventricular thiotepa and methotrexate. Cancer Treat Rep 1982; 66: 1549–51.
   Google Scholar
• Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treat-ment of leptomeningeal metastases from solid tumors: experi-ence with 90 patients. Cancer 1982; 49: 759–72.
   Google Scholar
• Bleyer WA, Drake JC, Chabner BA. Neurotoxicity and ele-vated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med 1973; 289: 770–3.
   Google Scholar
• Winkelman MD, Hines JD. Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study. Ann Neurol 1983; 14: 520–7.
   PubMedGoogle Scholar
• Eidinoff ML, Cheong L, Gambetta Gurpide E, Benua RS, Ellison RR. Incorporation of 5-iodouracil labelled with iodine-131 into the deoxyribonucleic acid of human leukaemic leucocytes following in vivo administration of 5-iodo-deoxyuridine labelled with iodine-131. Nature 1959; 183: 1686–7.
   Google Scholar
• Kassis Al, Fayad F, Kinsey BM, Sastry KSR, Taube RA, Adelstein SJ. Radiotoxicity of 1251 in mammalian cells. Radiat Res 1987; 111: 305–18.
   PubMed Web of Science ®Google Scholar
• Garrett C, Wataya Y, Santi DV. Thymidylate synthetase. Catalysis of dehalogenation of 5-bromo- and 5-iodo-2'-de-oxyuridylate. Biochemistry 1979; 18: 2798–804.
   Google Scholar
• Borsa J. Cytotoxic mechanisms of folate antagonists. Ann NY Acad Sci 1971; 186: 359–62.
   PubMedGoogle Scholar
• Bloomer WD, Adelstein SJ. Antineoplastic effect of iodine-125-labelled iododeoxyuridine. Int J Radiat Biol 1975; 27: 509–11.
   Google Scholar
• Baranowska-Kortylewicz J, Makrigiorgos GM, Van den Abbeele AD, Berman RM, Adelstein SJ, Kassis Al. 5-[1231]iodo-2'-deoxyuridine in the radiotherapy of an early ascites tumor model. Int J Radiat Oncol Biol Phys 1991; 21: 1541–51.
   PubMed Web of Science ®Google Scholar
• Kassis Al, Adelstein SJ, Mariani G. Radiolabeled nucleoside analogs in cancer diagnosis and therapy. Q J Nucl Med 1996; 40: 301–19.
   Google Scholar
• Sahu SK, Wen PYC, Foulon CF, et al. Intrathecal 5-[125I]iodo-2'-deoxyuridine in a rat model of leptomeningeal metastases. J Nucl Med 1997; 38: 386–90.
   PubMed Web of Science ®Google Scholar
• Kassis Al, Wen PY, Van den Abbeele AD, et al. 5-[1251]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats. J Nucl Med 1998; 39: 1148–54.
   Google Scholar
• Foulon CF, Adelstein SJ, Kassis Al. Kit formulation for the preparation of radiolabeled iododeoxyuridine by demetalla-tion. J Nucl Med 1996; 37(4, suppl): 1S–3S.
   Google Scholar
• Kassis Al, Sastry KSR, Adelstein SJ. Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger pro-cesses. Radiat Res 1987; 109: 78–89.
   Google Scholar
• Kassis Al, Sastry KSR, Adelstein SJ. Intracellular localisation of Auger electron emitters: biophysical dosimetry. Radiat Prot Dosim 1985; 13: 233–6.
   Google Scholar
• Sastry KSR, Howell RW, Rao DV, et al. Dosimetry of Auger emitters: physical and phenomenological approaches. In: Baverstock KF, Charlton DE, eds. DNA damage by Auger emitters. London: Taylor & Francis. 1988: 27–38.
   Google Scholar
• Charlton DE, Booz J. A Monte Carlo treatment of the decay of 125L Radiat Res 1981; 87: 10–23.
   Google Scholar
• Walicka MA, Adelstein SJ, Kassis AL Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: double-strand breaks. Radiat Res 1998; 149: 134–41.
   PubMed Web of Science ®Google Scholar
• Hofer KG, Hughes WL. Radiotoxicity of intranuclear tri-tium, 'iodine and 'iodine. Radiat Res 1971; 47: 94–109.
   PubMed Web of Science ®Google Scholar
• Porteous DD. The toxicity of 125IUdR in cultured mouse BP8 tumour cells. Br J Cancer 1971; 25: 594–7.
   PubMedGoogle Scholar
• Bradley EW, Chan PC, Adelstein SJ. The radiotoxicity of iodine-125 in mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA. Radiat Res 1975; 64: 555–63.
   Google Scholar
• Hofer KG, Harris CR, Smith JM. Radiotoxicity of intracellu-lar "Ga, '"I and 31-1: nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia. Int J Radiat Biol 1975; 28: 225–41.
   Google Scholar
• Chan PC, Lisco E, Lisco H, Adelstein SJ. The radio toxicity of iodine-125 in mammalian cells. II. A comparative study on cell survival and cytogenetic responses to 125IUdR, 131IUdR, and 31-ITdR. Radiat Res 1976; 67: 332–43.
   Google Scholar
• Chan PC, Lisco E, Lisco H, Adelstein SJ. Cell survival and cytogenetic responses to 121-UdR in cultured mammalian cells. Curr Top Radiat Res Q 1977; 12: 426–35.
   Google Scholar
• Kassis Al, Howell RW, Sastry KSR, Adelstein SJ. Positional effects of Auger decays in mammalian cells in culture. In: Baverstock KF, Charlton DE, eds. DNA damage by Auger emitters. London: Taylor & Francis. 1988: 1–13.
   Google Scholar
• Kassis Al, Makrigiorgos GM, Adelstein SJ. Implications of radiobiological and dosimetric studies of DNA-incorporated '"I: the use of the Auger effect as a biological probe at the nanometre level. Radiat Prot Dosim 1990; 31: 333–8.
   Google Scholar
• Warters RL, Hofer KG. Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site for radiation-induced division delay. Radiat Res 1977; 69: 348–58.
   PubMed Web of Science ®Google Scholar
• Mariani G, Di Sacco S, Volterrani D, et al. Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer. J Nucl Med 1996; 37(4, suppl): 22S–5S.
   Google Scholar
• Mariani G, Di Sacco S, Bonini R, et al. Biochemical modula-tion by 5-fluorouracil and 1-folinic acid of tumor uptake of intra-arterial 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer. Acta Oncol 1996; 35: 941–5.
   PubMed Web of Science ®Google Scholar